News
Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...
Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...
Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic ...
The U.S. National Science Foundation, in partnership with Capital One and Intel, today announced a $100 million investment to ...
BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.
Apple’s pivot reveals a core truth: real innovation requires knowing whether you’re strength is in being able to dream it, ...
In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...
As early as 2005, Gritz and colleagues drew attention to clinical trialists missing the potential impact of tobacco use on cancer treatment outcomes, as smoking status was rarely recorded in cancer ...
A groundbreaking new medical dataset is poised to revolutionize health care in Africa by improving chatbots' understanding of ...
Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...
The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s ...
2d
Kuwait Times on MSNKuwait’s DDI uses AI to identify new drug targets for diabetesKUWAIT: A senior scientist at Kuwait’s Dasman Diabetes Institute (DDI) has harnessed cutting-edge artificial intelligence to unlock new insights into the molecular mechanisms of diabetes, paving the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results